glp-1 receptor agonists effectiveness comparison Comparative of on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis GLP-1 Receptor Agonists for Weight

Both exenatide and liraglutide are relatively well tolerated, with dose-dependent nausea, vomiting, and diarrhea being the most commonly reported adverse events observed in clinical trials

Theories on how GLP-1 can prevent beta cell apoptosis, and possibly cause beta cell regeneration and proliferation: GLP-1 inhibits apoptosis Farilla and colleagues, demonstrated in their studies with the isolated human islets, which were separated into groups of those with and without GLP-1

Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk

If hair shedding begins three to six months after starting GLP-1 therapy and is diffuse rather than patchy or patterned, GLP-1 related telogen effluvium is the most likely cause

All GLP-1 therapy works best when combined with comprehensive lifestyle changes and personalized medical support

Gallstones in obesity and weight loss